Correlation Between GM and Innovation Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both GM and Innovation Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and Innovation Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and Innovation Pharmaceuticals, you can compare the effects of market volatilities on GM and Innovation Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of Innovation Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and Innovation Pharmaceuticals.
Diversification Opportunities for GM and Innovation Pharmaceuticals
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between GM and Innovation is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and Innovation Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovation Pharmaceuticals and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with Innovation Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovation Pharmaceuticals has no effect on the direction of GM i.e., GM and Innovation Pharmaceuticals go up and down completely randomly.
Pair Corralation between GM and Innovation Pharmaceuticals
Allowing for the 90-day total investment horizon General Motors is expected to under-perform the Innovation Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, General Motors is 23.85 times less risky than Innovation Pharmaceuticals. The stock trades about -0.14 of its potential returns per unit of risk. The Innovation Pharmaceuticals is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 0.05 in Innovation Pharmaceuticals on September 12, 2024 and sell it today you would lose (0.02) from holding Innovation Pharmaceuticals or give up 40.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
General Motors vs. Innovation Pharmaceuticals
Performance |
| Timeline |
| General Motors |
| Innovation Pharmaceuticals |
GM and Innovation Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GM and Innovation Pharmaceuticals
The main advantage of trading using opposite GM and Innovation Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, Innovation Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovation Pharmaceuticals will offset losses from the drop in Innovation Pharmaceuticals' long position.The idea behind General Motors and Innovation Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Innovation Pharmaceuticals vs. Cytodyn | Innovation Pharmaceuticals vs. Decision Diagnostics | Innovation Pharmaceuticals vs. Vystar Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |